Related Experiment Video
Updated: Jul 18, 2026

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
MDMA induces caspase-3 activation in the limbic system but not in striatum
Ilaria Tamburini1, Fabio Blandini, Marco Gesi
1Department of Human Morphology and Applied Biology, Univerity of Pisa, Via Roma 55, 56126 Pisa, Italy.
Abstract:
Several studies, carried out in chronic (+/-) 3,4-methylenedioxymethamphetamine (MDMA) abusers, have shown memory loss and cognitive impairment, as well as persistent electroencephalographic changes. This suggests that, at least in humans, forebrain areas, including the limbic system, might be altered by MDMA. Consistently, recent experimental evidences suggest that, in rodents, MDMA, besides effects on the basal ganglia, produces alterations in the hippocampus. Therefore, the aim of the present article was to investigate whether treatment with MDMA produces activation of the caspase-3 enzyme, which is part of an enzymatic pathway involved in cell death, within limbic areas (i.e., hippocampus, amygdala, and piriform cortex) and striatum. A marked induction of caspase-3 activity was demonstrated in the amygdala and hippocampus, although MDMA did not affect caspase-3 activity neither in the striatum nor in the frontal cortex. These data indicate that limbic structures possess a high sensitivity to MDMA with respect to the activation of at least one step in the apoptotic pathway. Potential implications and pitfalls of such an experimental observation are reported.
Insights
MDMA abuse is linked to cognitive deficits. This study found that MDMA activates cell death pathways in the amygdala and hippocampus, suggesting these brain areas are sensitive to the drug.
Area of Science:
- Neuroscience
- Toxicology
- Cell Biology
Background:
- Chronic 3,4-methylenedioxymethamphetamine (MDMA) use is associated with memory loss and cognitive impairment in humans.
- Studies suggest MDMA affects forebrain areas, including the limbic system and hippocampus, potentially through alterations in neuronal pathways.
Purpose of the Study:
- To investigate MDMA's effect on caspase-3 enzyme activity, a key indicator of apoptosis (programmed cell death).
- To determine if MDMA induces apoptosis in specific limbic areas (hippocampus, amygdala, piriform cortex) and the striatum.
Main Methods:
- Rodent models were used to assess caspase-3 activity following MDMA treatment.
- Enzyme activity was measured in the hippocampus, amygdala, piriform cortex, and striatum.
Main Results:
- MDMA significantly increased caspase-3 activity in the amygdala and hippocampus.
- No significant changes in caspase-3 activity were observed in the striatum or frontal cortex.
Conclusions:
- Limbic structures, specifically the amygdala and hippocampus, are highly sensitive to MDMA, exhibiting activation of the apoptotic pathway.
- These findings highlight potential neurotoxic mechanisms of MDMA in brain regions critical for emotion and memory.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway

